Alvotech (ALVO) Undervalued? Biosimilar Pipeline Progress
Alvotech (ALVO) Stock Valuation: Pipeline Promise Meets Market Skepticism NEW YORK — Alvotech (NASDAQ: ALVO) finds itself at a critical crossroads, where the ambitious trajectory of its drug pipeline is clashing head-on with a skeptical equity market. Investors are currently grappling with a stark disconnect between the company’s operational milestones and its trading price, leaving … Read more